{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:09:00Z","timestamp":1785265740399,"version":"3.55.0"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"DOI":"10.12788\/cutis.1176","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T20:01:19Z","timestamp":1744056079000},"source":"Crossref","is-referenced-by-count":2,"title":["Dupilumab in the Treatment of Pemphigoid Gestationis"],"prefix":"10.12788","volume":"115","author":[{"given":"Kevin","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5043","container-title":["Cutis"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/issues\/articles\/CT115003102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T20:01:20Z","timestamp":1744056080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/cutis\/article\/272304\/autoimmune-diseases\/dupilumab-treatment-pemphigoid-gestationis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,1]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.12788\/cutis.1176","relation":{},"subject":[],"published":{"date-parts":[[2025,3,1]]}}}